Cutaneous carcinoma with mixed histology: A potential etiology for skin cancer recurrence and an indication for Mohs microscopically controlled surgical excision

Southern Medical Journal

Volumn 98, Issue 7, 2005, Pages 740-747

  Cohen, Philip R ^a   Schulze, Keith E ^a   Nelson, Bruce R ^a,b  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b Dermatologic Surgery Center of Houston   (United States)

Author keywords

Basal cell carcinoma; Cutaneous carcinoma; Mixed histology; Mohs; Mohs micrographic surgery; Mohs microscopically controlled surgery; Recurrence; Skin cancer; Squamous cell carcinoma

Indexed keywords

AGED; ARTICLE; BASAL CELL CARCINOMA; CANCER GROWTH; CANCER INVASION; CANCER RECURRENCE; CASE REPORT; CHEMOSURGERY; DIAGNOSTIC ERROR; DIFFERENTIAL DIAGNOSIS; FEMALE; FULL THICKNESS SKIN GRAFT; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; PHYSICAL EXAMINATION; SKIN BIOPSY; SKIN CARCINOMA; SQUAMOUS CELL CARCINOMA; SURGICAL TECHNIQUE; TREATMENT INDICATION;

AGED; CARCINOMA, BASAL CELL; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; MALE; MIXED TUMOR, MALIGNANT; MOHS SURGERY; NEOPLASM RECURRENCE, LOCAL; SKIN NEOPLASMS;

EID: 23044511467     PISSN: 00384348     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.SMJ.0000166674.09383.EC     Document Type: Article

References (87)

1. Bath-Hextall F, Bong J, Perkins W, et al. Interventions for basal cell carcinoma of the skin: systematic review. BMJ 2004;329:705.
2. Martinez JC, Otley CC. The management of melanoma and nonmelanoma skin cancer: a review for the primary care physician. Mayo Clin Proc 2001;76:1253-1265.
3. Wennberg AM. Basal cell carcinoma-new aspects of diagnosis and treatment. Acta Derm Venereol 2000;209:5-25.
4. McGovern TW, Leffell DJ. Mohs surgery: the informed view [editorial]. Arch Dermatol 1999;135:1255-1259.
5. Thissen MRTM, Neumann MHA, Schouten LJ. A systematic review of treatment modalities for primary basal cell carcinomas. Arch Dermatol 1999;135:1177-1183.
6. Goldman GD. Squamous cell carcinoma: a practical approach. Semin Cutan Med Surg 1998;17:80-95.
7. Fleming TD, Amonette R, Monaghan T, et al. Principles of management of basal and squamous cell carcinoma of the skin. Cancer 1995;75:699-704.
8. Vargo NL. Basal and squamous cell carcinomas: an overview. Semin Oncol Nurs 1991;7:13-25.
9. Swanson NA. Basal cell carcinoma: treatment modalities and recommendations. Primary Care 1983;10:443-458.
10. Albright SD III. Treatment of skin cancer using multiple modalities. J Am Acad Dermatol 1982;7:143-171.
11. Kuflik EG. Crypsurgery for skin cancer: 30 year experience and cure rates. Dermatol Surg 2004;30:297-300.
12. Kokoszka A, Scheinfeld N. Evidence-based review of the use of cryosurgery in treatment of basal cell carcinoma. Dermatol Surg 2003;29:566-571.
13. Holt PJA. Cryotherapy for skin cancer: results over a 5-year period using nitrogen spray cryosurgery. Br J Dermatol 1988;119:231-240.
14. Spiller WF, Spiller RF. Treatment of basal cell epithelioma by curettage and electrodesiccation. J Am Acad Dermatol 1984;11:808-814.
15. Salasche SJ. Curettage and electrodesiccation in the treatment of midfacial basal cell epithelioma. J Am Acad Dermatol 1983;8:496-503.
16. Urosevic M, Dummer R. Immunotherapy for nonmelanoma skin cancer: does it have a future? Cancer 2002;94:477-485.
17. McDonald RRA, Georgouras K. Treatment of basal cell carcinoma with ntrlesional interferon alpha: a case report and literature review. Australas J Dermatol 1992;33:81-86.
18. Cornell RC, Greenway HT, Tucker SB, et al. Intralesional interferon therapy for basal cell carcinoma. J Am Acad Dermatol 1990;23:694-700.
19. Villa AM, Berman B. Immunomodulators for skin cancer. J Drugs Dermatol 2004;3:533-539.
20. Marmur ES, Schmults CD, Goldberg DJ. A review of laser and photodynamic therapy for the treatment of nonmelanoma skin cancer. Dermatol Surg 2004;30:264-271.
21. Soler AM, Warloe T, Berner A, et al. A follow-up study of recurrence and cosmesis in completely responding superficial and nodular basal cell carcinoma treated with methyl 5-aminolaevulinate-based photodynamic therapy alone and with prior curettage. Br J Dermatol 2001;145:467-471.
22. Gold MH, Goldman MP. 5-Aminolevulinic acid photodynamic therapy: where we have been and where we are going. Dermatol Surg 2004;30:1077-1084.
23. Kwan W, Wilson D, Moravan V. Radiotherapy for locally advanced basal cell and squamous cell carcinomas of the skin. In J Radiation Oncology Biol Phys 2004;60:406-411.
24. Locke J, Karimpour S, Young G, et al. Radiotherapy for epithelial skin cancer. Int J Radiation Oncology Biol Phys 2001;51:748-755.
25. Morrison WH, Garden AS, Ang KK. Radiation therapy for nonmelanoma skin carcinomas. Clin Plast Surg 1997;24:719-729.
26. Brodland DG, Zitelli JA. Surgical margins for excision of primary cutaneous squamous cell carcinoma. J Am Acad Dermatol 1992;27:241-248.
27. Wolf DJ, Zitelli JA. Surgical margins for basal cell carcinoma. Arch Dermatol 1987;123:340-344.
28. Huang CC, Boyce SM. Surgical margins of excision for basal cell carcinoma and squamous cell carcinoma. Semin Cutan Med Surg 2004;23:167-173.
29. Epstein E. Fluorouracil paste treatment of thin basal cell carcinomas. Arch Dermatol 1985;121:207-213.
30. McGillis ST, Fein H. Topical treatment strategies for non-melanoma skin cancer and precursor lesions. Semin Cutan Med Surg 2004;23:174-183.
31. Eklind J, Tartler U, Maschke J, et al. Imiquimod to treat different cancers of the epidermis. Dermatol Surg 2003;29:890-896.
32. Cowen E, Mercurio MG, Gaspari AA. An open case series of patients with basal cell carcinoma treated with topical 5% imiquimod cream. J Am Acad Dermatol 2002;47:S240-S248.
33. Lawrence CM. Mohs surgery of basal cell carcinoma-a critical review. Br J Plast Surg 1993;46:599-606.
34. Miller PK, Roenigk RK, Brodland DG, et al. Cutaneous micrographic surgery: Mohs procedure. Mayo Clin Proc 1992;67:971-980.
35. Rowe DE, Carroll RJ, Day CL Jr. Mohs surgery is the treatment of choice for recurrent (previously treated) basal cell carcinoma. J Dermatol Surg Oncol 1989;15:424-431.
36. Swanson NA. Mohs surgery: technique, indications, applications, and the future. Arch Dermatol 1983;119:761-773.
37. Robins P, Dzubow LM, Rigel DS. Squamous-cell carcinoma treated by Mohs' surgery: an experience with 414 cases in a period of 15 years. J Dermatol Surg Oncol 1981;7:800-801.
38. Turner RJ, Leonard N, Malcolm AJ, et al. A retrospective study of outcome of Mohs' micrographic surgery for cutaneous squamous cell carcinoma using formalin fixed sections. Br J Dermatol 2000; 142:752-757.
39. Swetter SM, Yaghmai D, Egbert BM. Infiltrative basal cell carcinoma occurring in sites of biopsy-proven nodular basal cell carcinoma. J Cutan Pathol 1998;25:420-425.
40. Dixon AY, Lee SH, McGregor DH. Factors predictive of recurrence of basal cell carcinoma. Am J Dermatol 1989;11:222-232.
41. Sexton M, Jones DB, Maloney ME. Histologic pattern analysis of basal cell carcinoma. Study of a series of 1039 consecutive neoplasms. J Am Acad Dermatol 1990;23:1118-1126.
42. Edmundson WF. Microscopic grading of cancer and its practical implication. Arch Dermatol Syph 1948;57:141-150.
43. Broders AC. Squamous cell carcinoma of the skin. Ann Surg 1921;73:141-160.
44. Lever WF, Schaumburg-Lever G. Tumors and Cysts of the Epidermis, in: Histopathology of the Skin, Philadelphia, J.B. Lippincott Company, 1990, ed 7, pp 523-577.
45. Frierson HF Jr, Cooper PH. Prognostic factors in squamous cell carcinoma of the lower lip. Hum Pathol 1986;17:346-354.
46. Boyd AS, Rapini RP. Cutaneous collision tumors. An analysis of 69 cases and review of the literature. Am J Dermatopathol 1994;16:253-257.
47. Martin RCG II, Edwards MJ, Cawte TG, et al. Basosquamous carcinoma: analysis of prognostic factors influencing recurrence. Cancer 2000;88:1365-1369.
48. Borel DM. Cutaneous basosquamous carcinoma: review of the literature and report of 35 cases. Arch Pathol 1973;95:293-297.
49. Montgomery H. Basal squamous cell epithelioma. Arch Dermatol Siphylol 1928;18:50-73.
50. Lang PG Jr, Maize JC. Histologic evolution of recurrent basal cell carcinoma and treatment implications. J Am Acad Dermatol 1986;14:186-196.
51. Dellon AL. Histologic study of recurrent basal cell carcinoma. Plast Reconstr Surg 1985;75:853-859.
52. Oram Y, Orengo I, Griego RD, et al. Histologic patterns of basal cell carcinoma based upon patient immunostatus. Dermatol Surg 1995;21:611-614.
53. Zagrodnik B, Kempf W, Seifert B, et al. Superficial radiotherapy for patients with basal cell carcinoma: recurrence rates, histologic subtypes, and expression of p53 and Bcl-2. Cancer 2003;98:2708-2714.
54. Saldanha G, Fletcher A, Slater DN. Basal cell carcinoma: a dermatopathological and molecular biological update. Br J Dermatol 2003;148:195-202.
55. Sloane JR. The value of typing basal cell carcinoma in predicting recurrence after surgical excision. Br J Dermatol 1977;96:127-132.
56. Jacobs GH, Rippey JJ, Altini M. Prediction of aggressive behavior in basal cell carcinoma. Cancer 1982;49:533-537.
57. Dixon AY, Lee SH, McGregor DH. Histologic evolution of basal cell carcinoma. Am J Dermatopathol 1991;13:241-247.
58. Dixon AY, Lee SH, McGregor DH. Histologic features predictive of basal cell carcinoma recurrence: results of a multivariate analysis. J Cutan Pathol 1993;20:137-142.
59. Immerman SC, Scanlon EF, Christ M, et al. Recurrent squamous cell carcinoma of the skin. Cancer 1983;51:1537-1540.
60. Rowe DE, Carroll RJ, Day CL Jr. Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip: implications for treatment modality selection. J Am Acad Dermatol 1992;26:976-990.
61. Mehrany K, Weenig RH, Pittelkow MR, et al. High recurrence rates of basal cell carcinoma after Mohs surgery in patients with chronic lymphocytic leukemia. Arch Dermatol 2004;140:985-988.
62. Orengo IF, Salasche SJ, Fewkes J, et al. Correlation of histologic subtypes of primary basal cell carcinoma and number of Mohs stages required to achieve a tumor-free plane. J Am Acad Dermatol 1997;37:395-397.
63. Lindgren G, Larko O. Long-term follow-up of cryotherapy of basal cell carcinoma of the eyelid. J Am Acad Dermatol 1977;36:742-746.
64. Mallon E, Dawber R. Cryosurgery in the treatment of basal cell carcinoma: assessment of one and two freeze-thaw cycle schedules. Dermatol Surg 1996;22:854-858.
65. Kuflik EG, Gage AA. The five-year cure rate achieved by cryosurgery for skin cancer. J Am Acad Dermatol 1991;24:1002-1004.
66. Spencer JM, Tannenbaum A, Sloan L, et al. Does inflammation contribute to the eradication of basal cell carcinoma following curettage and electrodesiccation? Dermatol Surg 1997;23:625-631.
67. Silverman MK, Kopf AW, Grin CM, et al. Recurrence rates of treated basal cell carcinomas. Part 2: curettage-electrodesiccation. J Dermatol Surg Oncol 1991;17:720-726.
68. Kopf AW, Bart RS, Schrager D, et al. Curettage-electrodesiccation treatment of basal cell carcinoma. Arch Dermatol 1977;113:439-443.
69. Dubin N, Kopf AW. Multivariate risk score for recurrence of cutaneous basal cell carcinoma. Arch Dermatol 1983;119:373-377.
70. Ikic D, Padovan I, Pipic N, et al. Interferon reduces recurrences of basal cell and squamous cell cancers. Int J Dermatol 1995;34:58-60.
71. Stenquist B, Wennberg AM, Gisslen H, et al. Treatment of aggressive basal cell carcinoma with intralesional interferon: evaluation of efficacy by Mohs surgery. J Am Acad Dermatol 1992;27:65-69.
72. Naidenov N, Dencheva R, Tsankov N. Recurrence rate of basal cell carcinoma after topical aminolevulinic acid-based photodynamic therapy. Acta Dermatovenereol Croat 2004;12:157-161.
73. Silverman MK, Kopf AW, Gladstein AH, et al. Recurrence rates of treated basal cell carcinomas. Part 4: x-ray therapy. J Dermatol Surg Oncol 1992;18:549-554.
74. Silverman MK, Kopf AW, Bart RS, et al. Recurrence rates of treated basal cell carcinomas. Part 3: surgical excision. J Dermatol Surg Oncol 1992;18:471-476.
75. Rowe DE, Carroll RJ, Day CL Jr. Long-term recurrence rates in previously untreated (primary) basal cell carcinoma: implications for patient follow-up. J Dermatol Surg Oncol 1989;15:315-328.
76. Hauben DJ, Zirkin H, Mahler D, et al. The biologic behavior of basal cell carcinoma: analysis of recurrence in excised basal cell carcinoma: part II. Plast Reconstr Surg 1982;69:110-116.
77. Bart RS, Schrager D, Kopf AW, et al. Scapel excision of basal cell carcinomas. Arch Dermatol 1978;114:739-742.
78. Reymann F. Treatment of basal cell carcinoma of the skin with 5-fluoruracil ointment: a 10-year follow-up study. Dermatologica 1979;158:368-372.
79. Hengge UR, Ruzicka T. Topical immunomodulation in dermatology: potential of Toll-like receptor agonists. Dermatol Surg 2004;30:1101-1112.
80. Smeets NWJ, Kuijpers DIM, Nelemans P, et al. Mohs' micrographic surgery for treatment of basal cell carcinoma of the face-results of a retrospective study and review of the literature. Br J Dermatol 2004; 151:141-147.
81. Boztepe G, Hohenleutner S, Landthatler M, et al. Munich method of micrographic surgery for basal cell carcinomas: 5-year recurrence rates with life-table analysis. Acta Derm Venereol 2004;84:218-222.
82. Lawrence CM. Mohs' micrographic surgery for basal cell carcinoma. Clin Exp Dermatol 1999;24:130-133.
83. Eliezri YD, Cohen PR. Cancer recurrence following Mohs micrographic surgery: a mechanism of tumor persistence. Plast Reconstr Surg 1992; 90:121-125.
84. Rigel DS, Robins P, Friedman RJ. Predicting recurrence of basal-cell carcinomas treated by microscopically controlled excision: a recurrence index score. J Dermatol Surg Oncol 1981;7:807-810.
85. Barrett TL, Greenway HT Jr, Massullo V, et al. Treatment of basal cell carcinoma and squamous cell carcinoma with perineural invasion. Adv Dermatol 1993;8:277-304.
86. Veness MJ. Perineural spread in head and neck skin cancer. Australas J Dermatol 2000;41:117-119.
87. Freeman RG, Duncan WC. Recurrent skin cancer. Arch Dermatol 1973;107:395-399.